Cancer Steering Committee

Gary Kelloff, M.D., National Cancer Institute, NIH (Interim Co-Chair)
David R. Parkinson, M.D., Nodality, Inc. (Co-Chair)
Aram Adourian, Ph.D., BG Medicine, Inc.
Donald A. Berry, Ph.D., The University of Texas M.D. Anderson Cancer Center
Bill Bro, Kidney Cancer Association
Peter F. Bross, M.D., Center for Biologic Evaluation and Review, FDA
Richard Buller, M.D., Ph.D., Pfizer
David Chang, M.D., Ph.D., Amgen
Adam Clark, Ph.D., Lance Armstrong Foundation
Carolyn Compton, M.D., Ph.D., National Cancer Institute, NIH
Louis J. DeGennaro, Ph.D., The Leukemia & Lymphoma Society
Louis Denis, M.D., Boehringer-Ingelheim
Chaitanya Divgi, M.D., University of Pennsylvania
Andrew Dorner, Ph.D., Millennium Pharmaceuticals, Inc.
James M. Doroshow, M.D., National Cancer Institute, NIH
Bernard Fine, M.D., Ph.D., Genentech/Roche
Yasuhiro Funahashi, Ph.D., Eisai Co.
Robert Gatenby, M.D., Moffitt Cancer Center and Research Institute, Florida
Gary Gordon, M.D., Ph.D., Abbott
Louise Grochow, M.D., AstraZeneca Pharmaceuticals
Steve Gutman, M.D., Blue Cross Blue Shield Associates
Christopher T. Harbison, Ph.D., Bristol Myers Squibb Company
Marc Hurlbert, Ph.D., Avon Foundation for Women
Robert Iannone, M.D., Merck Research Laboratories
J. Milburn Jessup, M.D., NCI, DCTD, Cancer Diagnosis Program
Gordon F. Kapke, Ph.D., Covance Central Laboratory Services, Inc.
Samir Khleif, M.D., US Food and Drug Administration
Douglas P. Malinowski, Ph.D., TriPath Oncology
Liz Mansfield, Office of In-Vitro Diagnostics, CDRH, FDA
Anne-Marie Martin, Ph.D., Glaxo Smith Kline
Stanislaw Mikulski, M.D., FACP, Hoffmann-LaRoche, Inc.
Gordon Mills, M.D., Ph.D., The University of Texas M.D. Anderson Cancer Center
Amir Mirza, Ph.D., XOMA, LLC
Anthony Murgo, M.D., M.S., FACP, FDA/CDER Office of Oncology
Erik M. Schaefer, Ph.D., Mesoscale Diagnostics, LLC
Andrew E. Schade, M.D., Ph.D., Eli Lilly and Company
Mitchell Schnall, M.D., Ph.D., University of Pennsylvania
Barry A. Siegel, M.D., Ph.D., Washington University School of Medicine
Ellen V. Sigal, Ph.D., Friends of Cancer Research
Catherine Novotny Smith, Ph.D., Battelle
Daniel C. Sullivan, M.D., National Cancer Institute, NIH
Chris H. Takimoto, M.D., Ph.D., Ortho Biotech Oncology R&D
Ena Wang, NIH